2nd International Pediatric Cardio-Oncology Conference | November 8-9, 2024
Topics to be covered include:
Emerging therapies in pediatric cardio-oncology, including ICI, targeted therapies, CAR T-cell
Approach to therapy in patients with cardiotoxicity
Cardiometabolic syndrome and cardiovascular risk factors in survivors of pediatric cancer
Cardio-protective strategies in cancer therapy
Surveillance for cardiotoxicity
Case presentations and patient discussion with experts in the field of cardio-oncology
2nd International Pediatric Cardio-Oncology Conference
Preliminary Agenda
Times are not final and subject to change
PRECONFERENCE ACTIVITIES
Thursday, November 8th, 2024
Hospital Tour | 3-4pm
Welcome Reception hosted by The International Cardio-Oncology Society (Evening)
Separate registration will be required | Exact time TBD
Friday, November 8th, 2024
Registration and breakfast available | 7-8am
Welcome | 8-8:30am
Focus Block 1 | 8:30-9:45am | New Therapeutics in Oncology and Implications for Pediatric Cardio-Oncology
Session Leaders: Rajaram Nagarajan, MD, MS – Texas Children’s; Eric Chow, MD, MPH – Seattle Children’s; and Louis S. Constine, MD – University of Rochester Medical Center
Evolution of Systematic Therapy and Impact on Cardiotoxicity Hodgkin Lymphoma as a Paradigm | 25-minute presentation | Kasey Leger, MD, MS – Seattle Children’s
Redefining the Impact of Radiotherapy on the Heart | 25-minute presentation | James Bates, MD - Emory
25-minute Combined Q&A
Break | 9:45-10am
Focus Block 2 | 10-11:30am | Surveillance, Managing Cardiovascular Risk Factors, and Cardiometabolic Risk in Cancer Survivors (+/- Exercise)
Session Leaders: Julia Steinberger, MD – University of Minnesota; Daniel A. Mulrooney, MD – St. Jude Children’s Research Hospital; and Lois Travis, MD, ScD – Indiana University
Surveillance and Managing CVD Risk Factors | Eric Chow, MD, MPH – Seattle Children’s | Julia Steinberger, MD – University of Minnesota | Suparna Clasen, MD – Indiana University School of Medicine
Cardiometabolic Risk in Cancer Survivors: Exercise interventions | Live Demo | Kirsten Ness, PT, PhD – St. Jude Children’s Research Hospital | Jessica Scott, PhD – Memorial Sloan Kettering Cancer Center
Lunch | 11:30-12:45pm
Focus Block 3 | 12:45-2pm | Clinical Cancer Survivorship Research: Learning Collaboratives, Lessons Learned, and Active Research Findings
Session Leaders: Steven E. Lipshultz, MD – University at Buffalo, Lois B. Travis, MD, ScD – Indiana University, and Leontien Kremer, MD, PhD – Princess Maxima Center
The Driving Force: Facilitating Research Teams | presentation | Lois B. Travis, MD, ScD – Indiana University
The Dutch LATER and European Survivorship Research Overview | presentation | Leontien CM Kremer, MD, PhD – Princess Maxima Center
Survivorship Research Overview from the CCSS and the St. Jude Life Cohort Study | presentation | Greg Armstrong, MD, MSCE – St. Jude Children’s Research Hospital
Implementation of Pediatric Cardio-Oncology Clinical Research to Improve Lifespan Quality of Life: Uses, Misuses, Abuses, and Disuses | presentation | Steven E. Lipshultz, MD – University at Buffalo
Break | 2-2:15pm
Focus Block 4 | |2:15-4:15pm | Cardiomyopathy, Heart Failure, and Cardiac Transplant - Cardiac Therapies and Management in Pediatric Cardio-Oncology
Session Leaders: Jeffrey A. Towbin, MD - Le Bonheur Children’s Hospital and Nathanya Baez-Hernandez, MD – UT Southwestern Medical Center
Not so simple: Understanding the cardiomyopathy spectrum in cancer patients | Jeffrey A. Towbin, MD – Le Bonheur Children’s Hospital
Cardiac Assessment in Cancer Patients | Luc Mertens, MD – The Hospital for Sick Children in Toronto
From Sub-Clinical to Advanced Cardiotoxicity: Cardiomyopathy Management in Pediatric Cancer Patients | Roundtable using case series | Jean Ballweg, MD – Helen DeVos Children’s Hospital | Hugo Martinez, MD –University of Tennessee Health Science Center | Jeffrey A. Towbin, MD – Le Bonheur Children’s Hospital | Sydney Elizer, MD – Phoenix Children’s Hospital | Mathew Mosgrove, MD - UT Southwestern Medical Center
Exploring the Limits in the Management of Heart Failure in Pediatric Cancer Patients | David Sutcliffe, MD — Children’s Mercy Kansas City
Break | 4:15-4:30pm
Advocacy Session | 4:30-5:30pm | Survivor Voices: Living with Cardiac Late Effects and Unmet Needs
Session Leaders: Marta Blanco – Sofia’s Hope and Jacob Adams, MD – University of Rochester
Introduction | 5-minute intro | Marta Blanco – Sofia’s Hope and Jacob Adams, MD – University of Rochester
Survivor Stories | 10 -12 minutes talks each followed by 15-20 min Q&A | Peter Wolf | Ania Buchacz | Kerri Becktell, MD – Children’s Hospital of Wisconsin
Abstract Oral Presentation | 5:30-6pm
Session Leaders: Steven E. Lipshultz, MD – University at Buffalo and Thomas D. Ryan, MD – Cincinnati Children’s
Top 3 abstracts, 7 min presentation with 3 min questions
Poster Session/Reception | 6-7pm
Faculty Dinner | 7:30-9:30pm
Saturday, November 9, 2024
Breakfast available 7-8am
CO Academy | 7:15-7:45am
Session Leaders: Thomas D. Ryan, MD – Cincinnati Children’s Hospital Medical Center and Jonathan Bender, MD – Cincinnati Children’s Hospital Medical Center
Optional learning sessions running concurrently:
Path 1 – Oncology for the Cardiologist – Jonathan Bender, MD – Cincinnati Children’s Hospital Medical Center
Path 2 – Cardiology for the Oncologist – Hugo Martinez, MD – University of Tennessee Health Science Center
Keynote Session | 8-9am: Social Determinants of Outcomes in Cardio-Oncology
Session Leaders: Thomas D. Ryan, MD – Cincinnati Children’s Hospital Medical Center and Greg Armstrong, MD, MSCE – St. Jude Children’s Research Hospital
40 min talk with time for discussion | Daniel Addison, MD – Ohio State University
Focus Block 5 | 9-10:30am | The Burden of Cancer Therapy on Childhood and Adolescent and Young Adult (AYA) Cancer Survivors, including Transitioning Care
Session Leaders: Anecita Fadol, PhD, APRN – MD Anderson Cancer Center and Louis S. Constine, MD – University of Rochester Medical Center
Unraveling the Complexities of the Genesis of Organ Toxicities from Cancer Therapy in Childhood Cancer Survivors | 15-minute presentation | Louis S. Constine, MD – University of Rochester Medical Center
Surveillance of Childhood and AYA Cancer Survivors | 15-minute presentation | Matthew Ehrhardt, MD – St. Jude Children’s Research Hospital
From Child-Centered Care to Adult-Oriented Care: Journey of Childhood and AYA Cancer Survivors | 15-minute presentation | Jikke Wams, PhD – Princess Maxima Center | Leontien Kremer, MD – Princess Maxima Center
Psychosocial Challenges of Young Adult Cancer Survivors and Mitigation Strategies | 15-minute presentation | Vanessa Aguilera Snyder, PsyD — Medical College of Wisconsin
Keys to Success for an AYA Transition | 15-minute presentation | Saro Armenian, MD – City of Hope Children’s Cancer Center
Panel Discussion | 15 minute
Break | 10:30-10:45am
Focus Block 6 | 10:45-11:45am: The Art of Patient Education in Pediatric Cardio-Oncology: Partnering with Advanced Practice Providers to Optimize Cardiovascular Health
Session Leaders: Anecita Fadol, PhD, APRN – MD Anderson Cancer Center and Molly Brickler, RN, MSN, CPNP-AC
Introduction of the Session | 5 minute intro | Anecita Fadol, PhD, APRN – MD Anderson Cancer Center
Challenging conversations in Pediatric Cardio-Oncology | 15-minute presentation | Molly M Brickler, RN, MSN, CPNP-AC – Children’s Wisconsin
Monitoring for Cardiovascular Toxicities during cancer treatment | 15-minute presentation | Angela Yarbrough, DNP, APRN, FNP-BC, CPHON – MD Anderson Cancer Center
Maintaining heart health in adult survivors of childhood cancer: Who’s responsible? | 15-minute presentation | Melissa Erickson, MD – University of Cincinnati
Box Lunch pick up | 11:45am-12pm
Focus Block 7/Lunch Session | 12-1:30pm: Adult Survivors of Pediatric Cancer (+/- ACHD Patients)
Session Leaders: Joseph Carver, MD – Perelman School of Medicine and Susan Dent, MD – Duke Cancer Center
Case: Long Term Survivors of Hodgkin’s with Multiple Late Effects | Case: Adult Congenital Heart Disease Survivor with New Acute Myeloid Leukemia (AML) | Case presentations | Michael Fradley, MD – Perelman School of Medicine | Anecita Fadol, PhD, APRN – MD Anderson Cancer Center | Anne Blaes, MD – University of Minnesota | Jonathan Menachem, MD – Vanderbilt University Medical Center
Session (Time TBD): Fireside Chat
Session Moderator: Steven E. Lipshultz, MD – University at Buffalo
Eugene Herman, PhD – NCI, Toxicology and Pharmacology Branch, DTP, DCTD | Rudolf Steiner, MD – University of Zurich
Closing Remarks | 2:30-2:40pm
Session Leaders: Steven E. Lipshultz, MD – University at Buffalo and Thomas D. Ryan, MD – Cincinnati Children’s
Enjoy Your Stay at
The Westin, Downtown Cincinnati
The Westin overlooks historic Fountain Square and is located in the heart of central business district with fine restaurants, shops, museums, theaters, and celebrated sports stadiums close-by.
Promotional & Exhibit Opportunities
If you are interested in promotional or exhibit opportunities at the second International Pediatric Cardio-Oncology Conference, please contact:
Ali Creaghead
513-803-1841
allison.creaghead@cchmc.org
Help Us Stay in Touch
The Second International Pediatric Cardio-Oncology Conference is jointly sponsored by Sofia’s Hope, the Cardio-Oncology Program at Cincinnati Children’s, and the Pediatric Cardiomyopathy Registry
The First International Pediatric Cardio-Oncology Conference is endorsed by the International Cardio-Oncology Society. IC-OS exists to advance the quality of cardio-oncology care by collaborating among educators, researchers, clinicians and allied professionals around the world.
Accreditation
In support of improving patient care, this activity has been planned and implemented by Cincinnati Children’s, Pediatric Cardiomyopathy Registry (PCMR), and Sofia’s Hope. Cincinnati Children’s is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: This activity has been approved for AMA PRA Category 1 Credit™. This activity is designed for the additional hours required for APRNs with prescriptive authority in Ohio.
ABP MOC Part 2: Successful completion of this CME activity enables the participant to earn MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
CNE: This activity is approved for continuing nursing education (CNE) contact hours. This activity is designed for the additional hours required for APRNs with prescriptive authority in Ohio.
This activity was planned by and for the healthcare team, and learners will receive Interprofessional Continuing Education (IPCE) credits for learning and change.
Pediatric Cardio-Oncology Webinar Series
Sponsored by Sofia's Hope and hosted by Heart University
PREVIOUS WEBINARS
Webinar 1: Updates in Pediatric Cardiology: watch now
Presenters
Steven Lipshultz, MD | Beginning with the End in Mind: Cardiotoxicity After Childhood Cancer
Thomas Ryan, MD, PhD | Cardio-Pulmonary Exercise Testing and Rehab in Cardio-Oncology
Steven Colan, MD, FACC, FASE | Differential Impact of Myocardial Mechanics in Acute Versus Late Doxorubicin Toxicity
Webinar 2: Surveillance for Cardiometabolic Disorders in Children and Adult Survivors of Childhood Cancers: watch now
Presenters
Ming Hui Chen, MD, MMSc, FACC, FASE | Case presentation
Julia Steinberger, MD, MS | Starting at the beginning - Components of metabolic syndrome and Cardiovascular risk factors in children who survived cancer
Dan Mulrooney, MD, MS | Cardiovascular Risk factors and Cardiovascular disease screening in adults who survived childhood cancers - the IGHG CAD guidelines
Elizabeth (Lieke) A. M. Feijen, PhD | Impact of alteration in anti-cancer protocols over time, on decreasing CV risk and disease
Webinar 3: The Pharmacogenetics of Anthracycline Related Cardiomyopathy in Survivors of Pediatric Cancers: watch now
Presenters
Javier Blanco, PhD | Myocardial Determinants for the Metabolism and Toxicity of Anthracycline Drugs
Smita Bhatia, MD, MPH | The Pharmacogenetics of Anthracycline-Related Cardiomyopathy in Survivors of Pediatric Cancers
Paul Burridge, PhD | The Role of the Genome in Doxorubicin-Induced Cardiotoxicity
Greg Armstrong, MD, MSCE | Moderator